Retatrutide Peptide: Dosage, Protocol, Reconstitution, and Weight Loss Mechanism Guide

Retatrutide Peptide

Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways. It is designed to reduce appetite, increase energy expenditure, and drive significant fat loss and metabolic improvements.

How Retatrutide Works

GLP-1 + GIP + Glucagon → Appetite ↓ → Energy Expenditure ↑ → Fat Loss ↑

Retatrutide combines incretin signaling (GLP-1, GIP) with glucagon activation. This results in both reduced calorie intake and increased metabolic output, making it more powerful than traditional GLP-1 therapies.

Retatrutide Protocol

Weeks 1–4

Dose2 mg

Units20 units (0.20 mL)

Weeks 5–8

Dose4 mg

Units40 units (0.40 mL)

Weeks 9–12

Dose6–8 mg

Units60–80 units

Weeks 13+

Dose8–12 mg

Units80–120 units

Frequency: Once weekly
Cycle Length: 24–48 weeks

Stepwise Titration (Why It Matters)

• Reduces nausea and GI side effects
• Improves adherence and comfort
• Allows metabolic adaptation
• Prevents overstimulation

Clinical Results

Clinical trials have shown up to ~24% body weight reduction over 48 weeks in higher-dose groups, making Retatrutide one of the most effective weight-loss therapies studied to date.

Monitoring During Use

• Body weight and appetite
• Blood glucose and insulin response
• Blood pressure
• GI tolerance

When & Where to Inject

• Inject once weekly (same day each week)
• SubQ: abdomen, thigh, or upper arm
• Rotate injection sites

Reconstitution & Dosing (10 mg Vial)

Vial 10 mg

Water 1.0 mL bacteriostatic

Concentration 10 mg/mL

Conversion 1 unit = 0.1 mg

Reconstitution Steps

Draw 1.0 mL bacteriostatic water

Inject slowly down vial wall

Gently swirl (do not shake)

Refrigerate immediately

Storage

Lyophilized: −20°C (−4°F)

Reconstituted: 2–8°C (36–46°F)

Use Window

Use within 30 days

Benefits

• Significant fat loss and weight reduction
• Appetite suppression
• Increased energy expenditure
• Improved metabolic health
• Potential insulin sensitivity improvement

Potential Side Effects

• Nausea (common early)
• Reduced appetite (can be strong)
• Fatigue during adjustment
• GI discomfort
• Limited long-term human data

Stacking Strategies

• Fat Loss: Retatrutide + Cagrilintide
• Metabolic: Retatrutide + NAD+
• Advanced: Retatrutide + MOTS-c

Important Disclaimer

Retatrutide is an investigational compound and not FDA-approved. This content is for educational purposes only.

Peptide Directory →